Harrison's Practice

Pork Tapeworm Infections and Cysticercosis

Definition

  • The pork tapeworm Taenia solium can cause 2 distinct forms of infection.
    • Taeniasis solium: adult tapeworm infection in the intestine
    • Cysticercosis: larval (cysticercal) infection in tissues
  • Humans are the only definitive hosts for T. solium.
  • Pigs are the usual intermediate hosts.

Epidemiology

  • Incidence
    • ~50 million people worldwide are infected by T. solium.
    • ~50,000 people die annually of cysticercosis because of central nervous system (CNS) complications.
    • Neurocysticercosis is the most common cause of seizures in the developing world.
    • The prevalence of neurocysticercosis is increasing in the U.S., primarily in California.
  • Age
    • All age groups are susceptible.
    • The age of infection depends on the time of ingestion of poorly cooked pork (taeniasis solium) or of Taenia eggs (cysticercosis).
  • Sex
    • Both sexes are equally affected.
  • Geographic distribution
    • T. solium exists worldwide but is most prevalent in:
      • Latin America
      • Sub-Saharan Africa
      • China
      • Southern and Southeast Asia
      • Eastern Europe
    • Cysticercosis occurs in industrialized nations largely as a result of the immigration of infected persons from endemic areas.

Risk Factors

  • Consumption of undercooked pork (risk factor for taeniasis solium)
  • Ingestion of T. solium eggs through close contact with a tapeworm carrier or an infected household member (risk factor for cysticercosis)
  • Current or prior residence in an endemic area

Etiology

  • Taenia solium (pork tapeworm)
    • Helminth, cestode
    • Normal life cycle
      • Eggs or gravid proglottids are passed with feces.
        • Eggs can survive for days to months in the environment.
      • Pigs become infected by ingesting vegetation contaminated with eggs or gravid proglottids.
        • Eggs hatch, invade the pig’s intestinal wall, and migrate to striated muscles, where they develop into cysticerci.
        • A cysticercus can survive for several years in the pig.
      • Humans become infected by ingesting raw or undercooked infected pork.
        • In the human small intestine, the cysticercus develops over 2 months into an adult tapeworm.
        • The tapeworm can survive for years.
      • Adult tapeworms produce proglottids that mature, become gravid, detach, and migrate to the anus or are passed in the stool.
  • Transmission
    • Taeniasis solium
      • Intestinal tapeworms are ingested in undercooked pork containing cysticerci.
    • Cysticercosis
      • T. solium eggs are ingested, usually as a result of close contact with a tapeworm carrier (as opposed to the ingestion of undercooked pork).
      • Autoinfection may occur if a person with an egg-producing tapeworm ingests eggs derived from his or her own feces.
  • Pathogenesis
    • Cysticerci can be found anywhere in the body but are most commonly detected in the brain, skeletal muscle, subcutaneous tissue, or eye.
    • The clinical presentation of cysticercosis depends on the number and location of cysticerci as well as the extent of associated inflammatory responses or scarring.
    • Hydrocephalus results from obstruction of cerebrospinal fluid (CSF) flow by cysticerci and accompanying inflammation or from CSF outflow obstruction due to arachnoiditis.

Associated Conditions

  • Up to 15% of patients with cysticercosis have concomitant taeniasis solium.

Symptoms & Signs

  • T. solium intestinal infection (taeniasis solium)
    • May be asymptomatic
    • Proglottids are passed with feces.
    • Infrequent signs/symptoms include:
      • Epigastric discomfort
      • Nausea
      • Polyphagia
      • Weight loss
      • Diarrhea
      • Vitamin B12 deficiency
  • Cysticercosis
    • Neurologic symptoms most common
    • Seizures (generalized or focal)
    • Hydrocephalus with signs of increased intracranial pressure
      • Headache
      • Nausea
      • Vomiting
      • Changes in vision
      • Dizziness
      • Ataxia
      • Confusion
      • Papilledema
      • Altered mental status
    • Neurocysticercosis is often classified as:
      • Parenchymal, with lesions confined to the parenchymal CNS tissues
      • Extraparenchymal, including racemose (subarachnoid) and ventricular involvement

Differential Diagnosis

Diagnostic Approach

Intestinal T. solium infection (taeniasis solium)

  • Infection is diagnosed by the detection of eggs or proglottids in stool or the perianal area.
    • Distinguishing T. saginata from T. solium requires examination of mature proglottids or the scolex.
    • Serologic tests are not helpful.

Cysticercosis

  • Diagnosis can be difficult.
  • Diagnostic certainty is possible only with definitive demonstration of the parasite (absolute criteria; see below).
  • In many cases, diagnostic certainty is not possible.
    • Instead, a clinical diagnosis is made on the basis of clinical presentation, radiographic studies, serologic tests, and exposure history.
  • In patients from endemic areas, the following combination of clinical criteria is almost always indicative of neurocysticercosis.
    • Single enhancing lesions presenting with seizures
    • Normal physical examination
    • No evidence of systemic disease (e.g., no fever, adenopathy, or chest radiographic abnormality)
    • Constellation of rounded CT lesions 5–20 mm in diameter with no midline shift
    • Evidence of calcifications on head CT (50% of patients)
  • A consensus conference has proposed criteria for diagnosis.
    • Absolute criteria
      • Histologic observation of the parasite in excised tissue
      • Funduscopic visualization of the parasite in the eye (in the anterior chamber, vitreous, or subretinal spaces)
      • Neuroimaging studies demonstrating cystic lesions that contain a characteristic scolex
    • Major diagnostic criteria
      • Neuroradiologic lesions suggestive of neurocysticercosis
      • Demonstration of antibodies to cysticerci in serum by enzyme-linked immunoelectrotransfer blot
      • Resolution of intracranial cystic lesions, either spontaneously or after therapy with antiparasitic agents
    • Minor diagnostic criteria
      • Neuroimaging findings consistent with but less characteristic of cysticercosis
      • Clinical manifestations suggestive of neurocysticercosis (e.g., seizures, hydrocephalus, altered mental status)
      • Evidence of cysticercosis outside the CNS (e.g., cigar-shaped soft-tissue calcifications)
      • Detection of antibody in CSF by enzyme-linked immunosorbent assay
    • Epidemiologic criteria
      • Exposure to a tapeworm carrier or to a household member infected with T. solium
      • Current or prior residence in an endemic area
      • Frequent travel to an endemic area
    • The diagnosis is confirmed in patients with either 1 absolute criterion or a combination of 2 major criteria, 1 minor criterion, and 1 epidemiologic criterion.
    • A probable diagnosis is supported by the fulfillment of:
      • 1 major criterion plus 2 minor criteria
      • 1 major criterion plus 1 minor criterion and 1 epidemiologic criterion
      • 3 minor criteria plus 1 epidemiologic criterion
  • Routine investigation before decisions are made about the need for medical therapy for suspected neurocysticercosis should include:
    • Ocular examination for ocular cysts
    • Careful physical examination of skin/soft tissues for nodules
    • Careful examination of the spine
      • Spinal cysticerci are a potential indication for surgical intervention.

Laboratory Tests

  • Antibody detection of cysticerci
    • An immunoblot assay using lentil lectin–purified glycoproteins is > 99% specific and highly sensitive.
    • Patients with single intracranial lesions or with calcifications may be seronegative.
    • With this assay, serum provides greater diagnostic sensitivity than CSF.
  • CSF analysis
    • While the CSF is usually abnormal in neurocysticercosis, CSF abnormalities are not pathognomonic.
    • Patients may have CSF pleocytosis with a predominance of lymphocytes, neutrophils, or eosinophils.
    • Protein levels may be elevated.
    • Glucose concentrations are usually normal but may be depressed.
    • Detection of CSF antibody may be useful when only unfractionated antigens are used.
  • Antigen detection assays, especially those detecting antigen in CSF, may also facilitate diagnosis.
    • However, these assays are not widely available, and published information on their use is limited.

Imaging

  • Neuroimaging (CT or MRI) (see Figure 1)
    • Findings that constitute the primary major diagnostic criterion include:
      • Cystic lesions with or without enhancement (e.g., ring enhancement)
      • ≥1 nodular calcifications (which may also have associated enhancement)
      • Focal enhancing lesions
    • Cysticerci in the brain parenchyma are usually 5–20 mm in diameter and rounded.
    • Cystic lesions in the subarachnoid space or fissures may enlarge up to 6 cm in diameter and may be lobulated.
    • For cysticerci within the subarachnoid space or ventricles, the walls may be very thin, and the cyst fluid is often isodense with CSF.
    • Obstructive hydrocephalus or enhancement of the basilar meninges may be the only finding on CT in extraparenchymal neurocysticercosis.
    • Cysticerci in the ventricles or subarachnoid space are usually visible to an experienced neuroradiologist on MRI or on CT with intraventricular contrast injection.
    • CT is more sensitive than MRI in identifying calcified lesions, whereas MRI is better for identifying cystic lesions and enhancement.

Diagnostic Procedures

  • Brain biopsy of lesions in cases where the diagnosis is uncertain and other diagnostic criteria are not met

Classification

  • Neurocysticercosis is often classified as:
    • Parenchymal, with lesions confined to the parenchymal CNS tissues
    • Extraparenchymal, including racemose (subarachnoid) and ventricular involvement

Treatment Approach

  • Intestinal T. solium infection is treated with antiparasitic drugs.
  • The management of neurocysticercosis is multidimensional and includes:
    • Symptom management with anticonvulsants if seizures occur
    • Medical management with antiparasitic agents and anti-inflammatory drugs (glucocorticoids)
    • Surgical management for extraparenchymal disease (e.g., ventricular, ocular, or spinal cysts)

Specific Treatments

Intestinal T. solium infection (taeniasis solium)

  • Single dose of praziquantel (10 mg/kg)
    • Praziquantel can evoke an inflammatory response in the CNS if concomitant cryptic cysticercosis is present.
  • Up to 15% of patients with cysticercosis have concomitant taeniasis solium.

Neurocysticercosis

  • Seizures can usually be controlled with antiepileptic agents (see Approach to Seizures).
    • If parenchymal lesions resolve without development of calcifications and patients remain free of seizures, antiepileptic therapy can usually be discontinued after 2 years.
  • Use of antiparasitic drugs
    • Complex decision that depends on the number, viability, location, and extent of lesions
    • Careful assessment of parenchymal versus extraparenchymal involvement required (see Symptoms & Signs)
      • Determines whether additional methods are necessary (e.g., surgical intervention for extraparenchymal involvement)
    • Conflicting data on utility of antiparasitic treatment
      • Some studies have shown a trend toward faster resolution of neuroradiologic abnormalities with treatment.
      • A recent trial demonstrated greater resolution of cysts and fewer generalized seizures in patients treated with albendazole.
      • Each patient must be assessed individually, given the complexity of the decision and the potential for neurologic deterioration due to the inflammatory response during antiparasitic treatment.
    • Preferred antiparasitic agents
      • Albendazole (15 mg/kg per day for 8–28 days)
        • Drug of choice; better CNS penetration than praziquantel
        • Must be taken with food for adequate absorption
      • Praziquantel (50–60 mg/kg daily in 3 divided doses for 15 days or 100 mg/kg in 3 doses given over a single day) is an alternative.
      • Both agents may increase the inflammatory response around the dying parasite, exacerbating seizures or hydrocephalus.
        • Thus, concomitant use of glucocorticoids is recommended.
        • Since glucocorticoids induce first-pass metabolism of praziquantel and may decrease its antiparasitic effect, cimetidine should be coadministered with praziquantel to inhibit its metabolism.
    • For patients with only calcified lesions or cysticercotic encephalitis, antiparasitic treatment is not recommended.
  • Hydrocephalus
    • Emergent reduction of intracranial pressure is the mainstay of therapy.
    • In the case of obstructive hydrocephalus or ventricular cysts, the preferred approach is surgical removal of the cysticercus.
    • An alternative approach is initially to perform a diverting procedure, such as ventriculoperitoneal shunting.
    • Historically, many shunts have had high failure rates, but lower failure rates have recently been attained with:
      • Treatment with antiparasitic drugs or
      • Long-term administration of immunomodulators (e.g., glucocorticoids) or
      • Use of flow-sensitive shunts
    • Open craniotomy to remove cysticerci is now required only infrequently.
    • For patients with subarachnoid cysts or giant cysticerci, glucocorticoids are needed to reduce arachnoiditis and accompanying vasculitis.
    • Most authorities recommend prolonged courses of antiparasitic drugs and shunting when hydrocephalus is present.
  • In cases with cerebral edema and elevated intracranial pressure due to large numbers of inflamed lesions, glucocorticoids are the mainstay of therapy, and antiparasitic drugs should be avoided.
  • For ocular and spinal medullary lesions, drug-induced inflammation may cause irreversible damage.
    • Most patients should be managed surgically and should be screened for cysts in these locations before antiparasitic therapy is initiated.

Monitoring

  • Patients should be monitored serially during treatment, given the risk for neurologic deterioration in the setting of inflammatory reactions to dying parasites.
  • Patients should be followed for ongoing seizures after treatment and should undergo serial CNS imaging.

Complications

  • Chronic meningitis
  • Arachnoiditis
  • Hydrocephalus
  • Stroke
  • Seizures

Prognosis

  • Most patients with parenchymal cysticercosis either remain asymptomatic or develop a self-limited seizure disorder.
  • The presence of calcifications in the brain (inactive cysts) has been associated in some series with a risk of ongoing seizures.
  • Extraparenchymal neurocysticercosis (subarachnoid, ventricular, or spinal) carries a relatively poor prognosis.
  • Subarachnoid disease
    • Previously associated with a case-fatality rate of ~50%
    • Prognosis is much improved with a combination of:
      • Shunting procedures for hydrocephalus
      • Antiparasitic agents
      • Surgical extirpation of cysts, when required

Prevention

  • Measures for prevention of intestinal T. solium infection entail the killing of cysticerci by:
    • Adequate cooking of infected pork
    • Exposure to temperatures as low as 56 °C for 5 minutes
    • Refrigeration or salting for long periods
    • Freezing at –10 °C for 9 days
  • Cysticercosis is prevented by minimizing opportunities for ingestion of fecally derived eggs through:
    • Good personal hygiene
    • Effective fecal disposal
    • Treatment and prevention of human intestinal infections

ICD-9-CM

  • 123.0 Taenia solium infection, intestinal form (includes pork tapeworm)
  • 123.1 Cysticercosis

See Also

Internet Sites

General Bibliography

  • DeGiorgio CM, Sorvillo F, Escueta SP: Neurocysticercosis in the United States: review of an important emerging infection. Neurology 64:, 2005  [PMID:15851761]
  • Del Brutto OH et al: Proposed diagnostic criteria for neurocysticercosis. Neurology 57:177, 2001  [PMID:11480424]
  • García HH et al: Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 15:747, 2002  [PMID:12364377]
  • Garcia HH et al: A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 350:249, 2004  [PMID:14724304]
  • Kelley R, Duong DH, Locke GE: Characteristics of ventricular shunt malfunctions among patients with neurocysticercosis. Neurosurgery 50:757, 2002  [PMID:11904026]
  • Nash TE et al: Calcific neurocysticercosis and epileptogenesis. Neurology 62:1934, 2004  [PMID:15184592]
  • Proaño JV et al: Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 345:879, 2001  [PMID:11565520]
  • Singh G, Prabhakar S: Taenia solium Cysticercosis: From Basic Science to Clinical Science. Wallingford, UK, CABI Publishing, 2002
  • Wallin MT, Kurtzke JF: Neurocysticercosis in the United States: review of an important emerging infection. Neurology 63:1559, 2004  [PMID:15534236]
  • White AC: Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annu Rev Med 51:187, 2000  [PMID:10774460]
  • This topic is based on Harrison’s Principles of Internal Medicine, 16th edition, chapter 204, Cestodes by AC White, Jr and PF Weller.

PEARLS

  • Eating pork is a risk factor for intestinal infection with T. solium but not for cysticercosis, which is acquired by the consumption of T. solium eggs.
  • Neurocysticercosis is the most common cause of seizures worldwide.
  • Treatment of neurocysticercosis is a complex decision that depends on the location, viability, and number of lesions.
  • Treatment of neurocysticercosis may involve a combination of techniques, including medical therapy, anti-inflammatory agents, and—in some cases—surgical intervention.
  • Up to 15% of patients with cysticercosis have concomitant taeniasis.

Pork Tapeworm Infections and Cysticercosis is a sample topic found in
Harrison's Practice.

To find other Harrison's Practice topics
please login or purchase a subscription.

Content Manager
Related Content
Cestodes
Laboratory Diagnosis of Parasitic Infections